Bullous pulmonary damage in users of intravenous drugs

D. S. Goldstein, J. P. Karpel, D. Appel, M. H. Williams

Research output: Contribution to journalArticle

30 Scopus citations

Abstract

Among a large group of users of illicit intravenous drugs, the incidence of bullous pulmonary damage was noted to be 2 percent (6/387). Bullous damage was significantly different in the drug users than in those who did not use drugs. The drug users were significantly younger than the nonusers, their bullae were large and confined to the upper lobes, and α1-antitrypsin deficiency was very unlikely. These features strongly implicate intravenous drug abuse in the pathogenesis of these patients' bullous pulmonary damage.

Original languageEnglish (US)
Pages (from-to)266-269
Number of pages4
JournalChest
Volume89
Issue number2
DOIs
StatePublished - Jan 1 1986

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Bullous pulmonary damage in users of intravenous drugs'. Together they form a unique fingerprint.

  • Cite this

    Goldstein, D. S., Karpel, J. P., Appel, D., & Williams, M. H. (1986). Bullous pulmonary damage in users of intravenous drugs. Chest, 89(2), 266-269. https://doi.org/10.1378/chest.89.2.266